Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375985 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Single Administration Intravenous Treatment for Influenza
A Phase 1 study, sponsored by Sarepta Therapeutics.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01375985 is a Phase 1 study that was terminated before completion, run by Sarepta Therapeutics. The registered enrollment target is 8 participants.
The verdict
NCT01375985, a Phase 1 study, was terminated before completion, sponsored by Sarepta Therapeutics.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the safety and pharmacology of single administrations of AVI-7100, a candidate treatment for influenza.
Interventions
- DRUG Placebo
- DRUG AVI-7100
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01375985
The ClinicalTrials.gov registry entry for NCT01375985 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sarepta Therapeutics, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01375985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01375985 about?
NCT01375985 is a clinical study titled "Safety Study of Single Administration Intravenous Treatment for Influenza". The purpose of this study is to characterize the safety and pharmacology of single administrations of AVI-7100, a candidate treatment for influenza.
What is the current status of trial NCT01375985?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2011-06. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01375985?
The interventions under investigation include: Placebo (DRUG), AVI-7100 (DRUG).
Who is sponsoring clinical trial NCT01375985?
This trial is sponsored by Sarepta Therapeutics, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.